The Real Importance of Pre-Existing Comorbidities on Long-Term Mortality after Acute Kidney Injury

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorPEREIRA, Mariana B.
dc.contributor.authorZANETTA, Dirce M. T.
dc.contributor.authorABDULKADER, Regina C. R. M.
dc.date.accessioned2013-07-30T17:53:33Z
dc.date.available2013-07-30T17:53:33Z
dc.date.issued2012
dc.description.abstractBackground: The causes of death on long-term mortality after acute kidney injury (AKI) have not been well studied. The purpose of the study was to evaluate the role of comorbidities and the causes of death on the long-term mortality after AKI. Methodology/Principal Findings: We retrospectively studied 507 patients who experienced AKI in 2005-2006 and were discharged free from dialysis. In June 2008 (median: 21 months after AKI), we found that 193 (38%) patients had died. This mortality is much higher than the mortality of the population of Sao Paulo City, even after adjustment for age. A multiple survival analysis was performed using Cox proportional hazards regression model and showed that death was associated with Khan's index indicating high risk [adjusted hazard ratio 2.54 (1.38-4.66)], chronic liver disease [1.93 (1.15-3.22)], admission to non-surgical ward [1.85 (1.30-2.61)] and a second AKI episode during the same hospitalization [1.74 (1.12-2.71)]. The AKI severity evaluated either by the worst stage reached during AKI (P=0.20) or by the need for dialysis (P=0.12) was not associated with death. The causes of death were identified by a death certificate in 85% of the non-survivors. Among those who died from circulatory system diseases (the main cause of death), 59% had already suffered from hypertension, 34% from diabetes, 47% from heart failure, 38% from coronary disease, and 66% had a glomerular filtration rate <60 previous to the AKI episode. Among those who died from neoplasms, 79% already had the disease previously. Conclusions: Among AKI survivors who were discharged free from dialysis the increased long-term mortality was associated with their pre-existing chronic conditions and not with the severity of the AKI episode. These findings suggest that these survivors should have a medical follow-up after hospital discharge and that all efforts should be made to control their comorbidities.
dc.description.indexMEDLINE
dc.description.sponsorshipCAPES (""Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior'')
dc.identifier.citationPLOS ONE, v.7, n.10, article ID e47746, 11p, 2012
dc.identifier.doi10.1371/journal.pone.0047746
dc.identifier.issn1932-6203
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/1552
dc.language.isoeng
dc.publisherPUBLIC LIBRARY SCIENCE
dc.relation.ispartofPlos One
dc.rightsopenAccess
dc.rights.holderCopyright PUBLIC LIBRARY SCIENCE
dc.subject.otheracute-renal-failure
dc.subject.otheracute myocardial-infarction
dc.subject.otherreplacement therapy
dc.subject.otherperitubular capillaries
dc.subject.otherchronic dialysis
dc.subject.otherrisk-factor
dc.subject.otheroutcomes
dc.subject.otherdeath
dc.subject.othersurvival
dc.subject.otherdisease
dc.subject.wosMultidisciplinary Sciences
dc.titleThe Real Importance of Pre-Existing Comorbidities on Long-Term Mortality after Acute Kidney Injury
dc.typearticle
dc.type.categoryoriginal article
dc.type.versionpublishedVersion
dspace.entity.typePublication
hcfmusp.author.externalZANETTA, Dirce M. T.:Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil
hcfmusp.citation.scopus22
hcfmusp.contributor.author-fmusphcMARIANA BATISTA PEREIRA
hcfmusp.contributor.author-fmusphcREGINA CELIA RODRIGUES DE MORAES ABDULKADER
hcfmusp.description.articlenumbere47746
hcfmusp.description.issue10
hcfmusp.description.volume7
hcfmusp.origemWOS
hcfmusp.origem.pubmed23082206
hcfmusp.origem.scopus2-s2.0-84867628543
hcfmusp.origem.wosWOS:000311146900103
hcfmusp.publisher.citySAN FRANCISCO
hcfmusp.publisher.countryUSA
hcfmusp.relation.referenceAhlstrom A, 2005, INTENS CARE MED, V31, P1222, DOI 10.1007/s00134-005-2681-6
hcfmusp.relation.referenceAli T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756
hcfmusp.relation.referenceBagshaw SM, 2006, AM J KIDNEY DIS, V48, P402, DOI 10.1053/j.ajkd.2006.06.002
hcfmusp.relation.referenceBagshaw SM, 2009, NEPHROL DIAL TRANSPL, V24, P2739, DOI 10.1093/ndt/gfp159
hcfmusp.relation.referenceBarretti P, 1997, RENAL FAILURE, V19, P253
hcfmusp.relation.referenceBasile DP, 2004, CURR OPIN NEPHROL HY, V13, P1, DOI 10.1097/01.mnh.0000109576.66112.70
hcfmusp.relation.referenceBasile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887
hcfmusp.relation.referenceBihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b
hcfmusp.relation.referenceBrown JR, 2010, ANN THORAC SURG, V90, P1142, DOI 10.1016/j.athoracsur.2010.04.039
hcfmusp.relation.referenceCerda J, 2008, CLIN J AM SOC NEPHRO, V3, P881, DOI 10.2215/CJN.04961107
hcfmusp.relation.referenceChoi AI, 2010, KIDNEY INT, V78, P478, DOI 10.1038/ki.2010.171
hcfmusp.relation.referenceCoca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034
hcfmusp.relation.referenceCoca SG, 2010, KIDNEY INT, V78, P926, DOI 10.1038/ki.2010.259
hcfmusp.relation.referenceDeshpande P, 2011, HEPATOL INT, V5, P751, DOI 10.1007/s12072-011-9269-8
hcfmusp.relation.referenceFranca E, 2008, INT J EPIDEMIOL, V37, P891, DOI 10.1093/ije/dyn121
hcfmusp.relation.referenceGo AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031
hcfmusp.relation.referenceGoldberg A, 2009, KIDNEY INT, V76, P900, DOI 10.1038/ki.2009.295
hcfmusp.relation.referenceGoldberg R, 2008, ADV CHRONIC KIDNEY D, V15, P297, DOI 10.1053/j.ackd.2008.04.009
hcfmusp.relation.referenceHobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011
hcfmusp.relation.referenceJames MT, 2011, CIRCULATION, V123, P409, DOI 10.1161/CIRCULATIONAHA.110.970160
hcfmusp.relation.referenceKelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46
hcfmusp.relation.referenceKHAN IH, 1993, LANCET, V341, P415, DOI 10.1016/0140-6736(93)93003-J
hcfmusp.relation.referenceKhan IH, 1997, QJM-MON J ASSOC PHYS, V90, P781
hcfmusp.relation.referenceKhosla N, 2009, CLIN J AM SOC NEPHRO, V4, P1914, DOI 10.2215/CJN.01690309
hcfmusp.relation.referenceKramer AA, 1999, KIDNEY INT, V55, P2362, DOI 10.1046/j.1523-1755.1999.00460.x
hcfmusp.relation.referenceLafrance JP, 2010, AM J KIDNEY DIS, V56, P651, DOI 10.1053/j.ajkd.2010.05.011
hcfmusp.relation.referenceLafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636
hcfmusp.relation.referenceLevey AS, 1999, ANN INTERN MED, V130, P461
hcfmusp.relation.referenceLiano F, 2010, CLIN NEPHROL, V74, pS89
hcfmusp.relation.referenceLiano F, 2007, KIDNEY INT, V71, P679, DOI 10.1038/sj.ki.5002086
hcfmusp.relation.referenceLoef BG, 2005, J AM SOC NEPHROL, V16, P195
hcfmusp.relation.referenceLopes JA, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-9
hcfmusp.relation.referenceMacedo E, 2008, CURR OPIN CRIT CARE, V14, P660, DOI 10.1097/MCC.0b013e328317ee6e
hcfmusp.relation.referenceMathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171
hcfmusp.relation.referenceMehta RH, 2010, AM J CARDIOL, V106, P1728, DOI 10.1016/j.amjcard.2010.07.045
hcfmusp.relation.referenceMehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713
hcfmusp.relation.referenceNair S, 2002, HEPATOLOGY, V35, P1179, DOI 10.1053/jhep.2002.33160
hcfmusp.relation.referenceParikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987
hcfmusp.relation.referencePechman KR, 2009, AM J PHYSIOL-REG I, V297, pR1358, DOI 10.1152/ajpregu.91022.2008
hcfmusp.relation.referencePonce D, 2011, NEPHROL DIAL TRANSPL, V26, P3202, DOI 10.1093/ndt/gfr359
hcfmusp.relation.referenceSchiffl H, 2011, INT UROL NEPHROL
hcfmusp.relation.referenceSchiffl H, 2008, NEPHROL DIAL TRANSPL, V23, P2235, DOI 10.1093/ndt/gfn182
hcfmusp.relation.referenceSiew ED, 2010, KIDNEY INT, V77, P536, DOI 10.1038/ki.2009.479
hcfmusp.relation.referenceSingh P, 2010, CLIN J AM SOC NEPHRO, V5, P1690, DOI 10.2215/CJN.00830110
hcfmusp.relation.referenceThakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f
hcfmusp.relation.referenceWald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322
hcfmusp.relation.referenceWald R, 2012, AM J MED, V125, P585, DOI 10.1016/j.amjmed.2012.01.016
hcfmusp.relation.referenceWOODROW G, 1992, NEPHROL DIAL TRANSPL, V7, P230
hcfmusp.remissive.sponsorshipCAPES
hcfmusp.scopus.lastupdate2024-05-17
relation.isAuthorOfPublicationc5db7a40-0330-49df-8d33-c2dd0b12f57e
relation.isAuthorOfPublicatione26bbe2b-e1df-4d06-b342-53e1f0d9cd85
relation.isAuthorOfPublication.latestForDiscoverye26bbe2b-e1df-4d06-b342-53e1f0d9cd85
Arquivos
Pacote Original
Agora exibindo 1 - 1 de 1
Carregando...
Imagem de Miniatura
Nome:
art_PEREIRA_The_Real_Importance_of_Pre_Existing_Comorbidities_on_2012.PDF
Tamanho:
609.81 KB
Formato:
Adobe Portable Document Format
Descrição:
publishedVersion (English)